Indication

Acute myeloid leukemia

Acute myeloid leukemia is an aggressive hematologic malignancy characterized by the clonal proliferation and accumulation of immature myeloid precursors, or myeloblasts, within the bone marrow and peripheral blood. Read more about Acute myeloid leukemia

113 drugs 65 manufacturers

Advertisement

Drugs that treat it

Common Acute myeloid leukemia therapies.

Showing 37–45 of 113 drugs

DOXORUBICIN HCL

ANTHRACYCLINE ANTIBIOTICS·OSTEOSARCOMA OF BONE·+19
Laboratories Div

DOXORUBICIN HCL

ANTHRACYCLINE ANTIBIOTICS·OSTEOSARCOMA OF BONE·+19
MYLAN INSTITUTI

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES·RETINOBLASTOMA·+17
BAXTER/AMERINET

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES·RETINOBLASTOMA·+17
BAXTER/NOVAPLUS

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES·RETINOBLASTOMA·+17
Baxter Healthcare
Filter & compare in the drug finder →Opens the drug finder with Acute myeloid leukemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Acute myeloid leukemia.

Acute myeloid leukemia is an aggressive hematologic malignancy characterized by the clonal proliferation and accumulation of immature myeloid precursors, or myeloblasts, within the bone marrow and peripheral blood.

This rapid malignant expansion primarily affects the hematopoietic system in adults, although it can manifest across all age groups.

Pathophysiologically, the infiltration of leukemic blasts disrupts normal hematopoiesis, leading to severe bone marrow failure marked by cytopenias.

Consequently, patients frequently present with debilitating fatigue due to anemia, life-threatening infections secondary to neutropenia, and spontaneous bruising or hemorrhage driven by thrombocytopenia.

Personalize your experience

Follow Acute myeloid leukemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it